Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Claritas Pharmaceuticals Inc CLAZF

Claritas Pharmaceuticals, Inc., formerly Kalytera Therapeutics Inc, is a biotechnology company that is focused on developing R-107 for the treatment of vaccine-resistant coronavirus disease (COVID) strains. The Company’s products in development include R-107 for coronavirus disease and Viral Infections, R-107 and Vaccines, and CLA-1816 for treatment of pain. R-107 is designed to defeat COVID viruses on contact. R-107 targets the Achilles heel of COVID, the spike protein on the surface of the virus. R-107 releases nitric oxide, which attaches to a specific amino acid on the spike protein, thereby disabling the spike protein. The CLA-1816 provides effective pain reduction, without the risks of addiction or respiratory suppression that exist with opioid analgesics. CLA-1816 strongly binds with and activates the alpha3 glycine pain receptor in the spine. The Company has leased a laboratory, office, and archival space in Beverly, Massachusetts.


GREY:CLAZF - Post by User

Post by SizzlinSteakson Dec 29, 2017 12:23pm
146 Views
Post# 27246021

WOW that was a big dump

WOW that was a big dump
Level ll Quote for KALYTERA THERAPEUTICS INC (KALY: TSX Venture)
Bid Ask
Price Total Size # of Orders Price Total Size # of Orders
$0.40 11500 3 $0.41 4000 1
$0.395 14500 4 $0.415 12000 2
$0.39 107000 6 $0.42 60000 4
$0.385 2000 1 $0.43 3000 1
$0.38 13000 3 $0.435 1000 1
$0.375 2500 2 $0.44 100000 2
$0.37 20500 3 $0.47 50000 3
$0.365 2000 1 $0.475 5000 1
$0.36 53500 4 $0.48 57000 3
$0.355 29000 3 $0.485 19500 4

Bullboard Posts